BIOMEDICINE
Most drug approval processes in the EU are similar to those of the FDA, such as obtaining pre-approval for the use of drugs in clinical trials. Upon completion of clinical trials, FDA drug approvals follow a centralized pathway, while European approval can follow 3 different pathways, depending on the nature of the drug, timing, and manufacturer preference.
